Two CD26 forms were detected in mice [126], and we found two mRNAs in humans [127], but we do not know if these or the genetic variants of DPP4 (which were linked to clinicopathologic development of prostate cancer [128]) are involved in these differences. Here, DPP4 is linked to prostate carcinoma.